Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ChiCTR |
Last refreshed on:
|
18 April 2017 |
Main ID: |
ChiCTR-ONC-16009423 |
Date of registration:
|
2016-10-15 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
A study of tissue engineered trachea in the clinic application for treating lung trachea carcinoma
|
Scientific title:
|
A study of tissue engineered trachea in the clinic application for treating lung trachea carcinoma |
Date of first enrolment:
|
2016-12-01 |
Target sample size:
|
Case series:5; |
Recruitment status: |
Pending |
URL:
|
http://www.chictr.org.cn/showproj.aspx?proj=15981 |
Study type:
|
Observational study |
Study design:
|
Case series
|
Phase:
|
New Treatment Measure Clinical Study
|
|
Countries of recruitment
|
China
| | | | | | | |
Contacts
|
Name:
|
Tan Qiang
|
Address:
|
Block2, 7th floor, 241 West Huaihai Road, Shanghai
|
Telephone:
|
+86 13601860323 |
Email:
|
dr_tanqiang@sina.com |
Affiliation:
|
Shanghai Chest Hospital |
|
Name:
|
Yao Yaxian
|
Address:
|
Block2, 7th floor, 241 West Huaihai Road, Shanghai
|
Telephone:
|
+86 15216769608 |
Email:
|
yaxianyao@hotmail.com |
Affiliation:
|
Shanghai Chest Hospital |
| |
Key inclusion & exclusion criteria
|
Inclusion criteria: 1. more than 6cm long trachea resection for malignant trachea carcinoma, tumor invading trachea and benign trachea disease;
2. failed sleeve resection which needs airway substitute to preclude pneumonectomy.
Exclusion criteria: 1. the loss of trachea is less than 4cm instead of anastomosis;
2. Invasion of grade 1 and 2 bronchus, which will accept regular resection without pneumonectomy.
Age minimum:
18
Age maximum:
70
Gender:
Both
|
Health Condition(s) or Problem(s) studied
|
lung trachea carcinoma
|
Intervention(s)
|
Case series:Tissue engineered trachea;
|
Primary Outcome(s)
|
revascularization biomarker;
|
Source(s) of Monetary Support
|
Shanghai Hospital Development Center
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|